121 related articles for article (PubMed ID: 33747362)
1. Fine-mapping of two differentiated thyroid carcinoma susceptibility loci at 2q35 and 8p12 in Europeans, Melanesians and Polynesians.
Guibon J; Sugier PE; Kulkarni O; Karimi M; Bacq-Daian D; Besse C; Boland A; Adjadj E; Rachédi F; Rubino C; Xhaard C; Mulot C; Laurent-Puig P; Guizard AV; Schvartz C; Ortiz RM; Ren Y; Ostroumova E; Deleuze JF; Boutron-Ruault MC; Kesminiene A; De Vathaire F; Guénel P; Lesueur F; Truong T
Oncotarget; 2021 Mar; 12(5):493-506. PubMed ID: 33747362
[TBL] [Abstract][Full Text] [Related]
2. Fine-mapping of two differentiated thyroid carcinoma susceptibility loci at 9q22.33 and 14q13.3 detects novel candidate functional SNPs in Europeans from metropolitan France and Melanesians from New Caledonia.
Tcheandjieu C; Lesueur F; Sanchez M; Baron-Dubourdieu D; Guizard AV; Mulot C; Laurent-Puig P; Schvartz C; Truong T; Guenel P
Int J Cancer; 2016 Aug; 139(3):617-27. PubMed ID: 26991144
[TBL] [Abstract][Full Text] [Related]
3. Multiethnic genome-wide association study of differentiated thyroid cancer in the EPITHYR consortium.
Truong T; Lesueur F; Sugier PE; Guibon J; Xhaard C; Karimi M; Kulkarni O; Lucotte EA; Bacq-Daian D; Boland-Auge A; Mulot C; Laurent-Puig P; Schvartz C; Guizard AV; Ren Y; Adjadj E; Rachédi F; Borson-Chazot F; Ortiz RM; Lence-Anta JJ; Pereda CM; Comiskey DF; He H; Liyanarachchi S; de la Chapelle A; Elisei R; Gemignani F; Thomsen H; Forsti A; Herzig AF; Leutenegger AL; Rubino C; Ostroumova E; Kesminiene A; Boutron-Ruault MC; Deleuze JF; Guénel P; de Vathaire F
Int J Cancer; 2021 Jun; 148(12):2935-2946. PubMed ID: 33527407
[TBL] [Abstract][Full Text] [Related]
4. Confirmation of papillary thyroid cancer susceptibility loci identified by genome-wide association studies of chromosomes 14q13, 9q22, 2q35 and 8p12 in a Chinese population.
Wang YL; Feng SH; Guo SC; Wei WJ; Li DS; Wang Y; Wang X; Wang ZY; Ma YY; Jin L; Ji QH; Wang JC
J Med Genet; 2013 Oct; 50(10):689-95. PubMed ID: 23847140
[TBL] [Abstract][Full Text] [Related]
5. Gene network and biological pathways associated with susceptibility to differentiated thyroid carcinoma.
Kulkarni O; Sugier PE; Guibon J; Boland-Augé A; Lonjou C; Bacq-Daian D; Olaso R; Rubino C; Souchard V; Rachedi F; Lence-Anta JJ; Ortiz RM; Xhaard C; Laurent-Puig P; Mulot C; Guizard AV; Schvartz C; Boutron-Ruault MC; Ostroumova E; Kesminiene A; Deleuze JF; Guénel P; De Vathaire F; Truong T; Lesueur F
Sci Rep; 2021 Apr; 11(1):8932. PubMed ID: 33903625
[TBL] [Abstract][Full Text] [Related]
6. Novel genome-wide association study-based candidate loci for differentiated thyroid cancer risk.
Figlioli G; Köhler A; Chen B; Elisei R; Romei C; Cipollini M; Cristaudo A; Bambi F; Paolicchi E; Hoffmann P; Herms S; Kalemba M; Kula D; Pastor S; Marcos R; Velázquez A; Jarząb B; Landi S; Hemminki K; Försti A; Gemignani F
J Clin Endocrinol Metab; 2014 Oct; 99(10):E2084-92. PubMed ID: 25029422
[TBL] [Abstract][Full Text] [Related]
7. Genome-wide association study on differentiated thyroid cancer.
Köhler A; Chen B; Gemignani F; Elisei R; Romei C; Figlioli G; Cipollini M; Cristaudo A; Bambi F; Hoffmann P; Herms S; Kalemba M; Kula D; Harris S; Broderick P; Houlston R; Pastor S; Marcos R; Velázquez A; Jarzab B; Hemminki K; Landi S; Försti A
J Clin Endocrinol Metab; 2013 Oct; 98(10):E1674-81. PubMed ID: 23894154
[TBL] [Abstract][Full Text] [Related]
8. A Comprehensive Meta-analysis of Case-Control Association Studies to Evaluate Polymorphisms Associated with the Risk of Differentiated Thyroid Carcinoma.
Figlioli G; Elisei R; Romei C; Melaiu O; Cipollini M; Bambi F; Chen B; Köhler A; Cristaudo A; Hemminki K; Gemignani F; Försti A; Landi S
Cancer Epidemiol Biomarkers Prev; 2016 Apr; 25(4):700-13. PubMed ID: 26843521
[TBL] [Abstract][Full Text] [Related]
9. Genome-wide association and expression quantitative trait loci studies identify multiple susceptibility loci for thyroid cancer.
Son HY; Hwangbo Y; Yoo SK; Im SW; Yang SD; Kwak SJ; Park MS; Kwak SH; Cho SW; Ryu JS; Kim J; Jung YS; Kim TH; Kim SJ; Lee KE; Park DJ; Cho NH; Sung J; Seo JS; Lee EK; Park YJ; Kim JI
Nat Commun; 2017 Jul; 8():15966. PubMed ID: 28703219
[TBL] [Abstract][Full Text] [Related]
10. Novel genetic variants in differentiated thyroid cancer and assessment of the cumulative risk.
Figlioli G; Chen B; Elisei R; Romei C; Campo C; Cipollini M; Cristaudo A; Bambi F; Paolicchi E; Hoffmann P; Herms S; Kalemba M; Kula D; Pastor S; Marcos R; Velázquez A; Jarząb B; Landi S; Hemminki K; Gemignani F; Försti A
Sci Rep; 2015 Mar; 5():8922. PubMed ID: 25753578
[TBL] [Abstract][Full Text] [Related]
11. Common variants at the 9q22.33, 14q13.3 and ATM loci, and risk of differentiated thyroid cancer in the Cuban population.
Pereda CM; Lesueur F; Pertesi M; Robinot N; Lence-Anta JJ; Turcios S; Velasco M; Chappe M; Infante I; Bustillo M; García A; Clero E; Xhaard C; Ren Y; Maillard S; Damiola F; Rubino C; Salazar S; Rodriguez R; Ortiz RM; de Vathaire F
BMC Genet; 2015 Mar; 16():22. PubMed ID: 25879635
[TBL] [Abstract][Full Text] [Related]
12. Common variants at 9q22.33, 14q13.3, and ATM loci, and risk of differentiated thyroid cancer in the French Polynesian population.
Maillard S; Damiola F; Clero E; Pertesi M; Robinot N; Rachédi F; Boissin JL; Sebbag J; Shan L; Bost-Bezeaud F; Petitdidier P; Doyon F; Xhaard C; Rubino C; Blanché H; Drozdovitch V; Lesueur F; de Vathaire F
PLoS One; 2015; 10(4):e0123700. PubMed ID: 25849217
[TBL] [Abstract][Full Text] [Related]
13. An intergenic risk locus containing an enhancer deletion in 2q35 modulates breast cancer risk by deregulating IGFBP5 expression.
Wyszynski A; Hong CC; Lam K; Michailidou K; Lytle C; Yao S; Zhang Y; Bolla MK; Wang Q; Dennis J; Hopper JL; Southey MC; Schmidt MK; Broeks A; Muir K; Lophatananon A; Fasching PA; Beckmann MW; Peto J; Dos-Santos-Silva I; Sawyer EJ; Tomlinson I; Burwinkel B; Marme F; Guénel P; Truong T; Bojesen SE; Nordestgaard BG; González-Neira A; Benitez J; Neuhausen SL; Brenner H; Dieffenbach AK; Meindl A; Schmutzler RK; Brauch H; ; Nevanlinna H; Khan S; Matsuo K; Ito H; Dörk T; Bogdanova NV; Lindblom A; Margolin S; Mannermaa A; Kosma VM; ; ; Wu AH; Van Den Berg D; Lambrechts D; Wildiers H; Chang-Claude J; Rudolph A; Radice P; Peterlongo P; Couch FJ; Olson JE; Giles GG; Milne RL; Haiman CA; Henderson BE; Dumont M; Teo SH; Wong TY; Kristensen V; Zheng W; Long J; Winqvist R; Pylkäs K; Andrulis IL; Knight JA; Devilee P; Seynaeve C; García-Closas M; Figueroa J; Klevebring D; Czene K; Hooning MJ; van den Ouweland AM; Darabi H; Shu XO; Gao YT; Cox A; Blot W; Signorello LB; Shah M; Kang D; Choi JY; Hartman M; Miao H; Hamann U; Jakubowska A; Lubinski J; Sangrajrang S; McKay J; Toland AE; Yannoukakos D; Shen CY; Wu PE; Swerdlow A; Orr N; Simard J; Pharoah PD; Dunning AM; Chenevix-Trench G; Hall P; Bandera E; Amos C; Ambrosone C; Easton DF; Cole MD
Hum Mol Genet; 2016 Sep; 25(17):3863-3876. PubMed ID: 27402876
[TBL] [Abstract][Full Text] [Related]
14. Discovery of common variants associated with low TSH levels and thyroid cancer risk.
Gudmundsson J; Sulem P; Gudbjartsson DF; Jonasson JG; Masson G; He H; Jonasdottir A; Sigurdsson A; Stacey SN; Johannsdottir H; Helgadottir HT; Li W; Nagy R; Ringel MD; Kloos RT; de Visser MC; Plantinga TS; den Heijer M; Aguillo E; Panadero A; Prats E; Garcia-Castaño A; De Juan A; Rivera F; Walters GB; Bjarnason H; Tryggvadottir L; Eyjolfsson GI; Bjornsdottir US; Holm H; Olafsson I; Kristjansson K; Kristvinsson H; Magnusson OT; Thorleifsson G; Gulcher JR; Kong A; Kiemeney LA; Jonsson T; Hjartarson H; Mayordomo JI; Netea-Maier RT; de la Chapelle A; Hrafnkelsson J; Thorsteinsdottir U; Rafnar T; Stefansson K
Nat Genet; 2012 Jan; 44(3):319-22. PubMed ID: 22267200
[TBL] [Abstract][Full Text] [Related]
15. The common genetic variant rs944289 on chromosome 14q13.3 associates with risk of both malignant and benign thyroid tumors in the Japanese population.
Rogounovitch TI; Bychkov A; Takahashi M; Mitsutake N; Nakashima M; Nikitski AV; Hayashi T; Hirokawa M; Ishigaki K; Shigematsu K; Bogdanova T; Matsuse M; Nishihara E; Minami S; Yamanouchi K; Ito M; Kawaguchi T; Kondo H; Takamura N; Ito Y; Miyauchi A; Matsuda F; Yamashita S; Saenko VA
Thyroid; 2015 Mar; 25(3):333-40. PubMed ID: 25562676
[TBL] [Abstract][Full Text] [Related]
16. Fine mapping of 14q13 reveals novel variants associated with different histological subtypes of papillary thyroid carcinoma.
Jendrzejewski J; Liyanarachchi S; Eiterman A; Thomas A; He H; Nagy R; Senter L; Sworczak K; de la Chapelle A
Int J Cancer; 2019 Feb; 144(3):503-512. PubMed ID: 30350351
[TBL] [Abstract][Full Text] [Related]
17. Genetic signature of differentiated thyroid carcinoma susceptibility: a machine learning approach.
Brigante G; Lazzaretti C; Paradiso E; Nuzzo F; Sitti M; Tüttelmann F; Moretti G; Silvestri R; Gemignani F; Försti A; Hemminki K; Elisei R; Romei C; Zizzi EA; Deriu MA; Simoni M; Landi S; Casarini L
Eur Thyroid J; 2022 Oct; 11(5):. PubMed ID: 35976137
[TBL] [Abstract][Full Text] [Related]
18. Clinical implications of GWAS variants associated with differentiated thyroid cancer.
Jendrzejewski JP; Sworczak K; Comiskey DF; de la Chapelle A
Endokrynol Pol; 2019; 70(5):423-429. PubMed ID: 31681970
[TBL] [Abstract][Full Text] [Related]
19. TPO genetic variants and risk of differentiated thyroid carcinoma in two European populations.
Cipollini M; Pastor S; Gemignani F; Castell J; Garritano S; Bonotti A; Biarnés J; Figlioli G; Romei C; Marcos R; Cristaudo A; Elisei R; Landi S; Velázquez A
Int J Cancer; 2013 Dec; 133(12):2843-51. PubMed ID: 23754668
[TBL] [Abstract][Full Text] [Related]
20. Endometrial vezatin and its association with endometriosis risk.
Holdsworth-Carson SJ; Fung JN; Luong HT; Sapkota Y; Bowdler LM; Wallace L; Teh WT; Powell JE; Girling JE; Healey M; Montgomery GW; Rogers PA
Hum Reprod; 2016 May; 31(5):999-1013. PubMed ID: 27005890
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
